Doctor profile · Federal record
Dr. Kanwarpal Kahlon, M.D.
Hematology & Oncology Physician (CMS: Internal Medicine) · Internal Medicine Physician · Burbank, CA
- NPI 1275793846
- Accepts Medicare
- MIPS 84.9 / 100 · 2023
- 20 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
201 S Buena Vista St Ste 200
Burbank, CA 915054570
(818) 842-8252
fax (818) 841-8252 - Additional location
-
100 UCLA Medical Plaza Suite 550
Los Angeles, CA 900958032
(310) 794-4955
fax (310) 443-0477 - Additional location
-
100 UCLA Medical Plaza Suite 555
Los Angeles, CA 900958032
(310) 794-4955
fax (310) 443-0477 - Mailing address
-
5767 W Century Blvd Ste 400
Los Angeles, CA 900455631
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- August 20, 2019
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A103296
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275793846. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
22,725
Distinct HCPCS
10
Medicare allowed
$692,353
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1453 |
Injection, fosaprepitant, 1 mg | 8,100 | 23 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,501 | 17 | $54 | |
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,740 | 13 | $48 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 680 | 29 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 480 | 24 | $1 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 472 | 18 | $0 | |
J3480 |
Injection, potassium chloride, per 2 meq | 417 | 15 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 388 | 178 | $8 | |
J7050 |
Infusion, normal saline solution, 250 cc | 313 | 114 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 279 | 156 | $140 |
In context: peer comparison
Among 4 peers in Burbank Hematology & Oncology Physician, average services per provider: 726. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$68,287
Transactions
71
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Blueprint Medicines Corporation | 45 | $37,760.64 | |
| Genzyme Corporation | 10 | $18,153.35 | |
| Alexion Pharmaceuticals, INC. | 16 | $12,373.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
309
Patients
28
Total drug cost
$1,339,893
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 56 | 17 | $53,996 |
| Hydroxyurea | Generic | 36 | 11 | $1,093 |
| Prednisone | Generic | 34 | 0 | $465 |
| Acyclovir | Generic | 29 | 0 | $520 |
| Pegasys (Peginterferon Alfa-2A) | Brand | 24 | 0 | $100,014 |
| Venclexta (Venetoclax) | Brand | 18 | 0 | $149,339 |
| Xarelto (Rivaroxaban) | Brand | 18 | 0 | $28,444 |
| Herceptin Hylecta (Trastuzumab-Hyaluronidase-Oysk) | Brand | 17 | 0 | $89,566 |
| Promacta (Eltrombopag Olamine) | Brand | 14 | 0 | $189,928 |
| Revlimid (Lenalidomide) | Brand | 14 | 0 | $271,594 |
Hospital affiliations
Frequently asked questions
What is Dr. Kanwarpal Kahlon's medical specialty?
Dr. Kanwarpal Kahlon practices Hematology & Oncology Physician in Burbank, CA.
Where does Dr. Kanwarpal Kahlon practice?
Dr. Kanwarpal Kahlon practices at 201 S Buena Vista St Ste 200, Burbank, CA 915054570. Office phone: 8188428252.
What is Dr. Kanwarpal Kahlon's NPI?
Dr. Kanwarpal Kahlon's National Provider Identifier (NPI) is 1275793846, issued by NPPES.
Does Dr. Kanwarpal Kahlon accept Medicare assignment?
Yes. Dr. Kanwarpal Kahlon accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kanwarpal Kahlon commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS J1561). Source: CMS Medicare Physician & Other Practitioners file.